Mutational burden of hepatoblastomas: a role for the CX3CL1/CX3CR1 chemokine signaling pathway
T. Aguiar, M. Prates, S. Costa, T. Rodrigues, J. S. de Barros, A. C. Barbosa, M. Maschietto, R. Valieris, G. R. Fernandes, M. Cypriano, S. R. C. de Toledo, A. Major, I. Tojal, M. L. d. P. Apezzato, D. M. Carraro, , A. C. V. Krepischi
This study identifies CX3CL1/CX3CR1 pathway activation and a novel mutational signature in hepatoblastomas through exome sequencing and expression analysis.
bioRxiv · Feb 22, 2019 · PreprintCancer Biology